Cover Image
市場調查報告書

藥物輸送技術的全球市場:2016-2026的預測

Drug Delivery Technologies Market Forecast 2018-2028

出版商 Visiongain Ltd 商品編碼 233148
出版日期 內容資訊 英文 188 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物輸送技術的全球市場:2016-2026的預測 Drug Delivery Technologies Market Forecast 2018-2028
出版日期: 2018年02月01日 內容資訊: 英文 188 Pages
簡介

全球藥物輸送技術市場上的收益預計2020年達到2,591億美元。

本報告以全球藥物輸送技術技術市場為焦點,提供主要的藥物輸送技術,次級市場及主要國家市場的趨勢及預測,主要企業簡介,SWOT分析及專家的見解彙整。

第1章 報告概要

  • 全球藥物輸送技術市場概要
  • 全球藥物輸送技術市場區分
  • 推薦本報告的理由
  • 本報告的提供方法
  • 這個分析報告闡明的主要疑問
  • 主要讀者
  • 調查手法
  • 常見問題 (FAQ)
  • 相關報告
  • 關於Visiongain

第2章 藥物輸送技術:簡介

  • 藥物輸送技術 (DDT) :為了改善傳統治療藥的策略
  • 全球藥物輸送技術市場:給藥手段
  • 美國的法規
  • 生技藥品
  • 市場定義

第3章 藥物輸送技術:全球市場

  • 全球藥物輸送技術市場
  • 全球藥物輸送技術市場預測
  • 藥物輸送技術:促進要素、阻礙要素
  • 生技藥品:藥物輸送技術的促進成長要素
    • 全球生技藥品市場預測
    • 生技藥品的主要級
    • 單株抗體:生技藥品的最大部門
    • 胰島素注射液:主要的治療蛋白質市場區隔
    • 肝炎治療用的干擾素產品
  • 疫苗:未滿足需求的應對
    • 全球疫苗市場預測

第4章 藥物輸送技術的次級市場

  • 全球藥物輸送技術市場:各次級市場
  • 各市場區隔的市場佔有率的變化預測
  • 口服藥輸送技術
    • 口服藥輸送技術市場預測
    • 趨勢、發展
    • 口服藥輸送技術:促進要素、抑制因素
  • 吸入藥輸送技術
  • 注射/植入輸送技術
  • 經皮藥輸送技術
  • 眼藥輸送技術
  • 經鼻/口腔藥輸送技術

第5章 藥物輸送技術:主要國家市場

  • 全球藥物輸送技術市場:各地區的預測
    • 市場佔有率的變化預測
  • 美國的藥物輸送技術市場
    • 市場預測
    • Eli Lilly 成立藥物輸送中心
  • 歐盟5國的藥物輸送技術市場
    • 市場預測
    • 各國的年複合成長率
    • 各國的市場佔有率變化預測
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
  • 日本的藥物輸送技術市場
    • 市場預測
    • 先驅審查指定制度加速創新的藥物開發
  • 中國的藥物輸送技術市場
    • 市場預測
  • 印度的藥物輸送技術市場
    • 市場預測
  • 巴西的藥物輸送技術市場
    • 市場預測
  • 俄羅斯的藥物輸送技術市場
    • 市場預測
  • 韓國的藥物輸送技術市場
    • 市場預測
  • 墨西哥的藥物輸送技術市場
    • 市場預測
  • 其他藥物輸送技術市場

第6章 藥物輸送技術市場上的主要企業

  • Alkermes
  • 3M
  • Skyepharma
  • Becton Dickinson and Company (BD)
  • Antares Pharma
  • pSivida
  • Applied Pharma Research (APR)
  • Ethypharm
  • Glycologic
  • Nanopass Technologies

第7章 藥物輸送技術市場定性分析

  • 藥物輸送技術市場SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅

第8章 專家的見解

第9章 整體概述

  • 全球藥物輸送技術市場
    • 目前主要藥物輸送技術區分
    • 關注的藥物輸送技術企業
    • 主要的地區/國家市場
  • 全球藥物輸送技術市場預測
  • 藥物輸送技術市場未來
    • 經皮藥、注射藥輸送技術有高成長姿態
    • 生物藥物、生技仿製藥促進市場成長

第10章 用語

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0282

Title:
DRUG DELIVERY TECHNOLOGIES MARKET FORECAST 2018-2028
Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies.

What can be expected from the Drug Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2028, assessing data, trends, opportunities and prospects.

Our 188 page report provides 118 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national drug delivery technologies market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2018-2028 and other analyses show you commercial prospects

Besides revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading regional and national markets

How will leading national and regional markets perform to 2028? Our study forecasts revenues in national markets, including:

  • US
  • EU5 (Germany, France, UK, Spain and Italy)
  • Japan
  • China
  • India
  • Brazil
  • Russia
  • South Korea
  • Mexico
  • Rest of the World

Leading companies and potential for market growth

Visiongain forecasts overall revenue for the Drug Delivery Technologies Market will reach $217.7bn in 2018. We predict high revenue growth over the forecast period driven by big pharma seeking diversification of their top-selling products and a growing demand for more patient-friendly treatments in healthcare.

Our work analyses the key companies in the market. See visiongain's analysis of ten leading companies, including:

  • Alkermes
  • 3M
  • Skyepharma
  • Becton Dickinson and Company (BD)
  • Antares Pharma
  • pSivida
  • Applied Pharma Research (APR)
  • Ethypharm
  • Glycologic
  • NanoPass Technologies

A company profile gives you the following information where available:

  • Discussion of a company's activities and outlook including regional and national revenue shares
  • Historic revenue, analysis and discussion of company performance
  • Analysis of major products/services currently available on the market
  • Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the drug delivery technologies industry?

Our new report discusses issues and events affecting the drug delivery technologies market. You will find discussions, including qualitative analyses:

  • Highly fragmented and competitive market with significant variations in different geographic regions
  • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
  • Future opportunities for drug delivery technologies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Drug Delivery Technologies Market Forecast 2018-2028: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies report helps you

In summary, our 189-page report gives you the following knowledge:

  • Revenue forecasts to 2028 for the Drug Delivery Technologies market - discover the industry's prospects, finding promising places for investments and revenues
  • Revenue forecasts to 2028 for three major regional markets - US, EU5 and Rest of the World
  • Revenue forecasts to 2028 for the leading national markets - US, Germany, France, UK, Spain, Italy, Japan, China, India, Brazil, Russia, South Korea, Mexico and Rest of the World
  • Assessment of leading companies - analysis of services, business operations, revenue (where available) and mergers & acquisitions
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the drug delivery technologies market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Drug Delivery Technology Market Overview
  • 1.2. Global Drug Delivery Technologies Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who Is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Drug Delivery Technologies: An Introduction

  • 2.1. Drug Delivery Technologies: Strategies to Improve Existing Drugs
  • 2.2. The Global Drug Delivery Technology Market: Methods of Administration
    • 2.2.1. The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
    • 2.2.2. Sustained/Controlled Release Systems
    • 2.2.3. Oral Drug Delivery: Swallowing Drugs to Reach a Target
    • 2.2.4. Pulmonary Delivery: Delivered by Inhalation
    • 2.2.5. Injection as a Route of Drug Delivery
    • 2.2.6. Transdermal Delivery: More Patient-Friendly
    • 2.2.7. Various Transmucosal Delivery Routes for Delivery
    • 2.2.8. Ocular Delivery: Overcoming Unique Barriers
  • 2.3. Regulation in the US
    • 2.3.1. Regulation of Combination Products
    • 2.3.2. FDA Guidelines for Injectors
  • 2.4. Biopharmaceuticals
    • 2.4.1. An Introduction to the Biological Drugs Market
    • 2.4.2. Biologics: A Rising Drugs Market
    • 2.4.3. Biologics with Associated Drug Delivery Technologies
    • 2.4.4. PEGylated Interferons
    • 2.4.5. Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
    • 2.4.6. The Main Challenges Facing Biological Drug Delivery
  • 2.5. Market Definition

3. Drug Delivery Technology: Global Market 2018-2028

  • 3.1. The Global Drug Delivery Technology Market in 2017
  • 3.2. The Global Drug Delivery Technology Market Forecast 2018-2028
  • 3.3. Drug Delivery Technology: Drivers and Restraints 2018-2028
  • 3.4. Biologics: A Driver for Growth in Drug Delivery Technologies
  • 3.4.1. The Global Biological Drugs Market Forecast
    • 3.4.2. Leading Classes of Biological Drugs
    • 3.4.3. Monoclonal Antibodies: Largest Sector in Biologics
    • 3.4.4. Human insulin: Leading the Therapeutic Protein Segment
    • 3.4.5. Interferon Products for the Treatment of Hepatitis
  • 3.5. Vaccines: Meeting the Unmet Needs
    • 3.5.1. The Global Vaccines Market Forecast

4. Drug Delivery Technologies: Submarkets 2018-2028

  • 4.1. The Global Drug Delivery Technology Market by Submarkets
  • 4.2. How Will Segmental Market Shares Change to 2028?
  • 4.3. Oral Drug Delivery Technology
    • 4.3.1. Oral Drug Delivery Technology Market Forecast 2018-2028
    • 4.3.2. Trends and Developments
    • 4.3.3. Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.4. Inhalable Drug Delivery Technology
    • 4.4.1. Inhalable Drug Delivery Technology Market Forecast 2018-2028
    • 4.4.2. Trends and Developments
    • 4.4.3. Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.5. Injectable/Implantable Delivery Technology
    • 4.5.1. Injectable/Implantable Delivery Technology Market Forecast 2018-2028
    • 4.5.2. Trends and Developments
    • 4.5.3. Injectable/Implantable Delivery Technologies: Drivers and Restraints 2018-2028
  • 4.6. Transdermal Drug Delivery Technology
    • 4.6.1. Transdermal Drug Delivery Technology Market Forecast 2018-2028
    • 4.6.2. Trends and Developments
  • 4.7. Ocular Drug Delivery Technology
    • 4.7.1. Ocular Drug Delivery Technology Market Forecast 2018-2028
    • 4.7.2. Trends and Developments
  • 4.8. Nasal/Buccal Drug Delivery Technology
    • 4.8.1. Nasal/Buccal Drug Delivery Technology Market Forecast 2018-2028
    • 4.8.2. Trends and Developments

5. Drug Delivery Technologies: Leading National Markets 2018-2028

  • 5.1. Global Drug Delivery Technology Market: Regional Forecast 2018-2028
    • 5.1.1. How Will Regional Market Shares Change to 2028?
  • 5.2. US Drug Delivery Technology Market 2018-2028
    • 5.2.1. US Drug Delivery Technology Market Forecast 2018-2028
    • 5.2.2. Eli Lilly to Establish Drug Delivery Centre
  • 5.3. EU5 Drug Delivery Technology Market 2018-2028
    • 5.3.1. EU5 Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.2. EU5 Drug Delivery Technologies Market: CAGR (%) by Country, 2018-2028
    • 5.3.3. EU5 Markets: Changing Market Shares by Country, 2018-2028
    • 5.3.4. The German Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.5. The French Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.6. The UK Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.7. The Spanish Drug Delivery Technology Market Forecast 2018-2028
    • 5.3.8. The Italian Drug Delivery Technology Market Forecast 2018-2028
  • 5.4. Japanese Drug Delivery Technology Market 2018-2028
    • 5.4.1. Japanese Drug Delivery Technology Market Forecast 2018-2028
    • 5.4.2. The New Sakigake Designation System May Accelerate Innovative Drug Development
  • 5.5. Chinese Drug Delivery Technology Market 2018-2028
    • 5.5.1. Chinese Drug Delivery Technology Market Forecast 2018-2028
  • 5.6. Indian Drug Delivery Technology Market 2018-2028
    • 5.6.1. Indian Drug Delivery Technology Market Forecast 2018-2028
  • 5.7. Brazilian Drug Delivery Technology Market 2018-2028
    • 5.7.1. Brazilian Drug Delivery Technology Market Forecast 2018-2028
  • 5.8. Russian Drug Delivery Technology Market 2018-2028
    • 5.8.1. Russian Drug Delivery Technology Market Forecast 2018-2028
  • 5.9. South Korean Drug Delivery Technology Market 2018-2028
    • 5.9.1. South Korean Drug Delivery Technology Market Forecast 2018-2028
  • 5.10. Mexican Drug Delivery Technology Market 2018-2028
    • 5.10.1. Mexican Drug Delivery Technology Market Forecast 2018-2028
  • 5.11. Rest of the World Drug Delivery Technology Market Forecast 2018-2028

6. Leading Companies in the Drug Delivery Technology Market 2017

  • 6.1. Alkermes: Focused on Extended and Controlled Release
    • 6.1.1. Alkermes PLC
    • 6.1.2. Alkermes PLC: Company Overview
    • 6.1.3. Alkermes PLC: Recent Developments
  • 6.2. 3M
    • 6.2.1. 3M: Company Overview
    • 6.2.2. 3M Company: Product Portfolio
    • 6.2.3. 3M Company: Recent Developments
  • 6.3. Becton, Dickinson & Company: A History of Hypodermic Needles and Syringes
    • 6.3.1. Becton, Dickinson & Company: Company Overview
    • 6.3.2. Becton, Dickinson & Company: Recent Developments
  • 6.4. Intercell AG
    • 6.4.1. Intercell AG: Company Overview
  • 6.5. Altea Therapeutics Corporation
    • 6.5.1. Altea Therapeutics Corporation: Company Overview
  • 6.6. Antares Pharma: Leading the Needle-Free Injector Market
    • 6.6.1. Antares PharmaInc.: Company Overview
    • 6.6.2. Antares Pharma Inc.: Recent Developments
  • 6.7. pSivida:
    • 6.7.1. pSivida Corporation: Company Overview
    • 6.7.2. pSivida Corporation: Recent Developments
  • 6.8. Applied Pharma Research (APR)
    • 6.8.1. Applied Pharma Research S.A.: Company Overview
    • 6.8.2. Applied Pharma Research S.A.: Recent Developments
  • 6.9. Ethypharm
    • 6.9.1. Ethypharm S.A.: Company Overview
  • 6.10. Glycologic
    • 6.10.1. Glycologic Limited: Company Overview
  • 6.11. NanoPass Technologies
    • 6.11.1. NanoPass Technologies Ltd.: Company Overview
    • 6.11.2. NanoPass Technologies Ltd.: Recent Developments

7. Qualitative Analysis of the Drug Delivery Technology Market 2018-2028

  • 7.1. SWOT Analysis of the Drug Delivery Technology Market
  • 7.2. Strengths
    • 7.2.1. Increasing Competition and Patent Expiry in the Biologics Market
    • 7.2.2. The Rise of Biosimilars
    • 7.2.3. Increasing Global Diabetic Population
  • 7.3. Weaknesses
    • 7.3.1. Risk-Conscious Regulatory Bodies Will Make Approval Difficult
    • 7.3.2. Companies Need to Develop a More Liberal Mindset
  • 7.4. Opportunities
    • 7.4.1. Nanotechnology: Innovations That Will Benefit Drug Delivery
    • 7.4.2. Possible New Delivery Methods for Insulin
  • 7.5. Threats
    • 7.5.1. Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
    • 7.5.2. Cost Effective Solutions May Not Be Available

8. Conclusions

  • 8.1. The Global Drug Delivery Technologies Market in 2018
    • 8.1.1. Current Leading Drug Delivery Technology Segments
    • 8.1.2. Notable Drug Delivery Technology Companies
    • 8.1.3. Leading Regional/National Markets
  • 8.2. Global Drug Delivery Technology Market Forecast 2018-2028
  • 8.3. The Future of the Drug Delivery Technology Market
    • 8.3.1. Transdermal and Injectable Drug Delivery Technologies Set For High Growth
    • 8.3.2. Biologics and Biosimilars to Drive Market Growth

9. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: Global Drug Delivery Technologies Market Segmentation Overview 2018
  • Figure 3.1: The Global Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.2: Drug Delivery Technologies: Market Drivers and Restraints 2018-2028
  • Figure 3.3: Global Biological Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.4: Global Vaccines Market: Revenues ($bn) and AGR (%), 2018-2028
  • Figure 4.1: Leading Drug Delivery Market Segments: CAGR (%), 2018-2022
  • Figure 4.2: Leading Drug Delivery Market Segments: CAGR (%), 2022-2028
  • Figure 4.3: Leading Drug Delivery Market Segments: CAGR (%), 2018-2028
  • Figure 4.4: Market Shares (%) of Leading Drug Delivery Market Segments, 2017
  • Figure 4.5: Market Shares (%) of Leading Drug Delivery Market Segments, 2022
  • Figure 4.6: Market Shares (%) of Leading Drug Delivery Market Segments, 2028
  • Figure 4.7: Oral Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.8: Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.9: Inhalable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.10: Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.11: Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.12: Injectable/implantable Drug Delivery Technologies: Drivers and Restraints 2018-2028
  • Figure 4.13: Transdermal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.14: Ocular Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.15: Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.1: The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn), 2018
  • Figure 5.2: Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
  • Figure 5.3: Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2018-2022
  • Figure 5.4: Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
  • Figure 5.5: Global Drug Delivery Technology Market: CAGR (%) by Country/Region 2018-2028
  • Figure 5.6: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2017
  • Figure 5.7: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2022
  • Figure 5.8: Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2028
  • Figure 5.9: US Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.10: EU5 Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.11: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022
  • Figure 5.12: EU5 Drug Delivery Technology Market: by Country, 2022-2028
  • Figure 5.13: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2028
  • Figure 5.14: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2017
  • Figure 5.15: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2022
  • Figure 5.16: EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2028
  • Figure 5.17: German Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.18: French Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.19: UK Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.20: Spanish Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.21: Italian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.22: Japanese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.23: Chinese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.24: Indian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.25: Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.26: Russian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.27: South Korean Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.28: Mexican Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.29: Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.1: Alkermes PLC, Revenue, ($million), 2012-2016
  • Figure 6.2: Alkermes PLC, Geographical Presence Share (%), 2016
  • Figure 6.3: 3M, Revenue, ($million), 2012-2016
  • Figure 6.4: 3M, Product Segments Share (%), 2016
  • Figure 6.5: 3M, Geographical Presence Share (%), 2016
  • Figure 6.6: Becton, Dickinson & Company, Revenue, ($million), 2013-2017
  • Figure 6.7: Becton, Dickinson & Company, Geographical Presence Share (%), 2017
  • Figure 6.8: Becton, Dickinson & Company, Segment Share (%), 2017
  • Figure 6.9: Antares Pharma Inc., Revenue, ($million), 2013-2017
  • Figure 6.10: 6pSivida Corporation, Revenue, ($million), 2012-2016
  • Figure 6.11: pSivida Corporation, Product Segments Share (%), 2016
  • Figure 6.12: Ethypharm S.A., Revenue, ($million), 2012-2016

List of Tables

  • Table 1.1: Global Drug Delivery Technologies Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Region, 2018-2028 (Redacted Data)
  • Table 2.1: The Biopharmaceutics Classification System, Classification and Description
  • Table 2.2: Top 5 Biologics by Sales ($bn), 2018
  • Table 3.1: The Global Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.2: Global Biological Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.3: Global Vaccines Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.1: The Global Drug Delivery Technology Market by Submarkets: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.2: Leading Drug Delivery Market Segments: Share (%), 2017, 2022, and 2028
  • Table 4.3: Leading Drug Delivery Market Segments: Market Share (%), 2017
  • Table 4.4: Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.5: Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.6: Insulin Inhalers Withdrawal from the Market or Pipeline, 2017
  • Table 4.7: Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.8: Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.9: Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.10: Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.1: The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn) and Market Share (%), 2017
  • Table 5.2: Global Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Country/Region, 2018-2028
  • Table 5.3: Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
  • Table 5.4: Global Drug Delivery Technology Market: Revenue ($bn) and Market Share (%) by Country/Region, 2017, 2022 and 2028
  • Table 5.5: US Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.6: EU5 Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.7: EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022, 2022-2028 and 2018-2028
  • Table 5.8: EU5 Drug Delivery Technology Market: Market Size ($bn) and Market Share (%) by Country, 2017, 2022 and 2028
  • Table 5.9: German Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.10: French Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.11: UK Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.12: Spanish Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.13: Italian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.14: Japanese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.15: Chinese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.16: Indian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.17: Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
  • Table 5.18: Russian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.19: South Korean Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.20: Mexican Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.21: Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.1: Akermes PLC: Company Overview
  • Table 6.2: Alkermes PLC: Recent Developments
  • Table 6.3: 3M: Company Overview
  • Table 6.4: 3M: Product Portfolio
  • Table 6.5: 3M Company: Recent Developments
  • Table 6.6: Becton, Dickinson & Company: Company Overview
  • Table 6.7: Becton, Dickinson & Company: Recent Developments
  • Table 6.8: Intercell AG: Company Overview
  • Table 6.9: Altea Therapeutics Corporation: Company Overview
  • Table 6.10: Antares Pharma Inc.: Company Overview
  • Table 6.11: Antares Pharma Inc.: Recent Developments
  • Table 6.12: pSivida Corporation: Company Overview
  • Table 6.13: pSivida Corporation: Recent Developments
  • Table 6.14: Applied Pharma Research S.A.: Company Overview
  • Table 6.15: Applied Pharma Research S.A.: Recent Developments
  • Table 6.16: Ethypharm S.A.: Company Overview
  • Table 6.17: Glycologic Limited: Company Overview
  • Table 6.18: NanoPass Technologies Ltd.: Company Overview
  • Table 6.19: NanoPass Technologies Ltd.: Recent Developments
  • Table 7.1: SWOT Analysis of the Drug Delivery Technology Market, 2018-2028

Companies Listed

  • 3M
  • Acorda
  • Actavis
  • Adamis
  • Aleza Pharmaceuticals
  • Alkermes
  • Almirall
  • Alza
  • Antares Pharma
  • Applied Pharma Research
  • Aradigm
  • Astellas
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • BD
  • Biogen
  • BioGeneration Ventures
  • Bioject Medical Technologies
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CareFusion Corporation
  • Cephalon
  • Changchun BCHT
  • Chiesi
  • Chrono Therapeutics
  • Cilag
  • Cima Labs
  • Clearside
  • Cosmo Pharmaceuticals
  • CRISI Medical Systems
  • CTCBIO
  • Daiichi
  • Elan Drug Technologies
  • Elcam Medical
  • Eli Lilly
  • Ethypharm
  • Ferrer
  • Ferring
  • Flamel
  • Genentech
  • GlaxoSmithKline
  • Glycologic
  • Google
  • GSK
  • Haselmeir
  • Horizon Pharma
  • ImmusanT
  • Innovent Biologics
  • Insmed
  • Invion
  • iScience Interventional Corporation
  • J&J
  • Janssen
  • JCR Pharmaceuticals
  • Kyorin
  • MannKind
  • Meda Pharmaceuticals
  • Medac
  • Medimetrics
  • MedImmune
  • MedSciences Capital
  • Merck Serono
  • Mucosis
  • Mundipharma
  • Nanopass Technologies
  • Nektar Therapeutics
  • Nexvax2
  • NHTherapeutics
  • Novartis
  • Novo Nordisk
  • NuPathe
  • NV NOM
  • Oramed
  • OwenMumford
  • Pacira Pharmaceuticals
  • Pari Pharma
  • Permatec
  • Pfizer
  • PharmaJet
  • Presspart
  • ProStrakan
  • pSivida
  • Pulmagen
  • Ranbaxy
  • Rani Therapeutics
  • Recro Pharma
  • Regeneron Pharmaceuticals
  • Roche
  • Sandoz
  • Sanofi-Aventis
  • Santen
  • Shionogi
  • SHL Group
  • Shreya Life Sciences
  • Skyepharma
  • Smoofi
  • Spark Therapeutics
  • STADA Arzneimittel
  • Takeda
  • Teva
  • UU Holdings
  • Vetter Pharma
  • West Pharmaceuticals
  • Ypsomed

List of Organizations:

  • European Medicines Agency (EMA)
  • Ministry of Health, Labor and Welfare (MHLW)
  • The Centers for Disease Control and Prevention (CDC)
  • The Organisation for Economic Co-operation and Development (OECD)
  • UK National Health Service (NHS)
  • US Food & Drug Administration (FDA)
  • World Health Organisation (WHO)
Back to Top